Zhengye Biotechnology Holding Cash Flow Statement Analysis

Operating, investing, and financing activities in millions CNY

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Zhengye Biotechnology Holding Limited (ZYBT) - Annual data in millions CNY
BreakdownFY 2024FY 2023FY 2022FY 2021
Period EndingDec 2024Dec 2023Dec 2022Dec 2021
Operating Activities
Net Income13.4731.4646.7438.96
Depreciation & Amortization24.1623.9118.8016.01
Deferred Income Tax0.920.54-1.31-0.36
Change in Working Capital-0.98-20.28-66.60-33.71
Change in Accounts Receivable11.3131.04-24.72-28.50
Change in Inventory-5.88-12.90-12.33-12.34
Change in Accounts Payable-0.40-43.51-6.7118.11
Change in Other Working Capital-6.006.23-22.670.00
Other Operating Activities3.4716.628.660.00
Net Cash from Operating Activities41.0548.1817.3431.81
Investing Activities
Capital Expenditures-27.77-11.60-27.33-26.40
Purchases of Investments0.00-1.220.000.00
Sales/Maturities of Investments0.00-4.200.00-7.34
Other Investing Activities-14.080.000.000.00
Net Cash from Investing Activities-27.67-11.77-27.33-26.27
Financing Activities
Debt Repayment-2.74-54.89-64.97-22.00
Dividends Paid-16.02-39.45-21.43-11.05
Other Financing Activities-3.37-4.500.000.00
Net Cash from Financing Activities-22.13-18.9813.46-3.05
Summary
Effect of Forex Changes on Cash0.170.000.000.00
Net Change in Cash-8.5817.443.462.49
Cash at Beginning of Period27.199.756.283.80
Cash at End of Period18.6127.199.756.28
Free Cash Flow13.2736.58-9.995.41
Supplemental Disclosures
Interest Paid3.994.422.841.05
Income Taxes Paid0.1210.498.486.99